At what age is medulloblastoma most common and what are its typical neurological signs?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 19, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Medulloblastoma: Age Distribution and Neurological Presentation

Medulloblastoma is most common in children under 10 years of age, with peak incidence in the pediatric population (0-14 years), though it can occur in adults during their 3rd and 4th decades of life. 1, 2

Age Distribution

  • Pediatric predominance: Medulloblastoma accounts for 10-20% of all pediatric brain tumors and is the most common malignant brain tumor in children 1, 3
  • Peak age: Most cases occur before 10 years of age, with the highest incidence in children aged 0-14 years 2, 4
  • Incidence rate: 0.47 per 100,000 children aged 0-14 years in the United States 3
  • Adult cases: While much less common, medulloblastoma can occur in adults, typically in the 3rd and 4th decades of life (ages 20-40 years) 2
  • Gender: More frequent in males across all age groups 2

Age-Related Molecular Subtype Patterns

  • WNT-activated tumors: Most common in children aged 7-14 years 3
  • SHH-activated tumors: Can occur across age groups, including adults 3, 5

Neurological Signs and Symptoms

The neurological presentation is dominated by signs of increased intracranial pressure and cerebellar dysfunction, with symptoms typically developing over less than 3 months. 6, 2

Signs of Increased Intracranial Pressure (Most Common)

These occur because medulloblastoma typically arises in the cerebellum or fourth ventricle, causing obstruction of cerebrospinal fluid flow: 6, 2

  • Headache (often worse in the morning)
  • Nausea and vomiting (particularly morning vomiting)
  • Papilledema on fundoscopic examination
  • Lethargy and altered mental status
  • Macrocephaly (in infants with open fontanelles)

Cerebellar Signs

Due to the tumor's predilection for the cerebellar vermis and hemispheres: 6, 2

  • Ataxia (truncal and/or appendicular)
  • Dysmetria (impaired coordination of movements)
  • Intention tremor
  • Dysdiadochokinesia (inability to perform rapid alternating movements)
  • Nystagmus
  • Dysarthria (scanning speech)

Cranial Nerve Deficits

From brainstem compression or invasion: 2

  • Sixth nerve palsy (abducens nerve, causing diplopia)
  • Facial weakness (seventh nerve involvement)
  • Hearing loss (eighth nerve involvement)

Signs of Leptomeningeal Dissemination

Present in approximately 33% of cases at diagnosis: 2

  • Back pain (from spinal metastases)
  • Radicular pain
  • Lower extremity weakness
  • Bowel or bladder dysfunction
  • Cauda equina syndrome

Timeline and Pitfalls

  • Symptom duration: Typically brief, usually less than 3 months from onset to diagnosis 6, 2
  • Critical pitfall: The rapid progression of symptoms requires urgent neuroimaging; do not delay MRI if clinical suspicion is present 1
  • Imaging requirement: MRI of both brain AND spine with gadolinium contrast is mandatory at diagnosis to detect leptomeningeal dissemination, which occurs in one-third of cases and dramatically affects prognosis and treatment stratification 1, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

From the archives of the AFIP: medulloblastoma: a comprehensive review with radiologic-pathologic correlation.

Radiographics : a review publication of the Radiological Society of North America, Inc, 2003

Guideline

Medulloblastoma Prevalence and Characteristics in Pediatric Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Cellular and molecular pathology of medulloblastoma.

Journal of neuro-oncology, 1996

Guideline

Molecular Classification and Management of Medulloblastoma

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Medulloblastoma.

Clinical oncology (Royal College of Radiologists (Great Britain)), 2013

Related Questions

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.